2011 A randomized, double blind, placebo-controlled parallel group efficacy and safety trial of Study Drug
(10 and 25 mg administered orally once daily) over 24 weeks in patients with Type 2 diabetes mellitus with insufficient glycemic control despite a background therapy of piogltazone alone or in combination with metformin.
2011 A phase 2 , randomized, placebo-controlled, factorial , double blind, double dummy, parallel group, multicenter study to determine the efficacy and safety of 25 mg and 50 mg of safety drug in combination with Sitagliptin 100mg in subjects with type 2 diabetes mellitus.
2011 A randomized, double- blind, parallel –group, multicenter, placebo-controlled study of the safety and efficacy of study drug in the treatment of mild to moderate distal subungual onychomycosis of the toenail.
2011 A randomized, parallel group, dose-ranging, controlled, multicenter study to assess the efficacy and safety of study drug in the treatment of subjects with a venous leg ulcer
2015 A randomized, parallel group, dose-ranging, controlled, multicenter study to assess the efficacy and safety of study drug in the treatment of subjects with a venous leg ulcer
2017 A randomized, parallel group, dose-ranging, controlled, multicenter study to assess the efficacy and safety of study drug in the treatment of subjects with a venous leg ulcer